search
Back to results

Reducing Aggression Among People With an Intellectual Disability (PSYVB)

Primary Purpose

Aggression, Intellectual Disability

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Multivitamin, mineral & n-3 FA
Placebo
Sponsored by
Leiden University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Aggression focused on measuring Aggression, aggressive behavior, nutritional supplements, dietary supplements, vitamin, mineral, omega-3, n-3 fatty acids, intellectual disability

Eligibility Criteria

12 Years - 39 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • intellectual disability
  • living or day care in a health care organization
  • age 12 till 39 years
  • has a at least once a week an aggressive incident.

Exclusion Criteria:

  • Pregnancy
  • Breastfeeding
  • people with Williams syndrome, hyperparathyroid or hemochromatosis.
  • Current use of nutritional supplements and refusal to quit this use for the duration of the study.
  • Failure to complete the two-week run-in phase.
  • The use of the following medication: levothyroxine, methyldopa en levodopa

Sites / Locations

  • Trajectum
  • Gemiva-SVG
  • Schakenbosch
  • s Heeren Loo
  • Amerpoort
  • Syndion
  • Amarant

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Multivitamin, mineral & n-3 FA

Placebo

Arm Description

The daily supplementation of multivitamin- and mineral in 2 capsules and n-3 fatty acids in 2 softgel capsules.

The placebo consists of daily supplementation of 2 capsules with rice bran extract, hypromellose and 1.6 mg riboflavin. And 2 softgel capsules with a vegetable oil.

Outcomes

Primary Outcome Measures

Aggression
The amount of aggressive behavior registered with the Modified Overt Aggression Scale (MOAS).This is a four item aggression scale which distinguishes verbal aggression, aggression to objects, self-aggression and physical aggression to others.

Secondary Outcome Measures

Aggression and anti-social behavior
Aggressive- and anti-social behavior measured with the SDAS-11. An eleven item aggression scale. The severity of each item can range from 1 to 5 on a Likert scale.
Quality of Life IDQOL-16
Quality of life measured with the IDQOL-16.
Cortisol status
The cortisol status measured with hair analyses.
Microbiome
The micobiome measured with feces analysis.

Full Information

First Posted
June 16, 2017
Last Updated
March 8, 2021
Sponsor
Leiden University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03212092
Brief Title
Reducing Aggression Among People With an Intellectual Disability
Acronym
PSYVB
Official Title
Reducing Aggressive Behaviour Among People With an Intellectual Disability Through Supplementation of Vitamins, Minerals and n-3 Fatty Acids
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
January 15, 2018 (Actual)
Primary Completion Date
February 1, 2021 (Actual)
Study Completion Date
March 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Leiden University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study is an randomised controlled trial (RCT) to test whether supplementation of vitamins, minerals and n-3 fatty acids may reduce aggressive behavior in people with intellectual disabilities.
Detailed Description
Rationale: The prevalence of aggression among people with an intellectual disability is high. Previous studies have demonstrated the potential of multivitamin-, mineral-, and n-3 fatty acids (n-3FA) supplementation to reduce antisocial behavior and aggression among schoolchildren and prisoners. Objective: To test the hypothesis that multivitamin-, mineral-, and n-3 FA supplementation reduces aggression among adolescents and young adults with an intellectual disability. Study design: Pragmatic, randomised, double blind, placebo controlled, multicentre intervention study. Study population: People with an intellectual disability aged between 12-39 years, living at a care or treatment facility or having day care, who have shown aggressive behaviour. Intervention: During 16 weeks, people in the active condition receive 4 supplements daily: 2 Bonusan Multi Vital Forte Actief (Multi vitamin and mineral) and 2 Bonusan Omega-3 Forte (n-3 fatty acids) while people in the placebo condition receive 4 placebo capsules. Main study parameters/endpoints: The main study parameter is the number of aggressive incidents from baseline to endpoint (16 weeks post baseline), as measured using the Dutch version of the Modified Overt Aggression Scale (MOAS). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Clients who wish to participate enter a 2-week run-in phase during which they take 4 placebo capsules daily. After positive evaluation of this phase clients are randomised to either the active or control condition. Participants will then start the daily use of 4 supplement capsules or 4 placebo capsules, which continues for 16 weeks. At baseline and endpoint 2 questionnaires will be administered: the Intellectual Disability Quality of Life (IDQOL-16) and the Dutch Healthy Diet Food Frequency Questionnaire (DHD-FFQ). Small hair and faeces samples will be collected at baseline and 16 weeks. The data collection will take less than an hour per client and will take place at the location where the client resides. Aggression incidents will be registered by staff members using the MOAS. Also a staff member will fill in the Social Dysfunction Aggression Scale (SDAS) at baseline and endpoint, measuring observed levels of aggression and social dysfunction. The risks of participating in this study are minimal. The use of the Bonusan Multi Vital Forte Actief, or similar supplements has not been associated with any significant health risks and side effects. Potential benefits of participating in this study is an increase in quality of life through improved nutritional status, as well as a reduction of aggressive incidents. As this is a pragmatic trial in which the main objective is to determine whether the use of supplements has the potential to reduce the number of aggressive incidents among adolescents and young adults with an intellectual disability, it is imperative to include these subjects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aggression, Intellectual Disability
Keywords
Aggression, aggressive behavior, nutritional supplements, dietary supplements, vitamin, mineral, omega-3, n-3 fatty acids, intellectual disability

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study is a pragmatic multicenter randomized double-blind placebo-controlled intervention trial with an intervention period of 4 months. Since the washout period of several components of dietary supplements is unknown we chose a parallel design.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Placebo with the appearance as the dietary supplements
Allocation
Randomized
Enrollment
137 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Multivitamin, mineral & n-3 FA
Arm Type
Experimental
Arm Description
The daily supplementation of multivitamin- and mineral in 2 capsules and n-3 fatty acids in 2 softgel capsules.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
The placebo consists of daily supplementation of 2 capsules with rice bran extract, hypromellose and 1.6 mg riboflavin. And 2 softgel capsules with a vegetable oil.
Intervention Type
Dietary Supplement
Intervention Name(s)
Multivitamin, mineral & n-3 FA
Intervention Description
The 2 multi vitamin capsules with the two multi vitamin softgel capsules will be handed out once a day during a meal by the staff of the care organization. The compliance will be registered
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
The placebo of the multi vitamin capsules and the two multi vitamin softgel capsules will be handed out once a day during a meal by the staff of the care organization. The compliance will be registered
Primary Outcome Measure Information:
Title
Aggression
Description
The amount of aggressive behavior registered with the Modified Overt Aggression Scale (MOAS).This is a four item aggression scale which distinguishes verbal aggression, aggression to objects, self-aggression and physical aggression to others.
Time Frame
The aggression will be reported daily by the staff during a period of 18 weeks
Secondary Outcome Measure Information:
Title
Aggression and anti-social behavior
Description
Aggressive- and anti-social behavior measured with the SDAS-11. An eleven item aggression scale. The severity of each item can range from 1 to 5 on a Likert scale.
Time Frame
At baseline and in the 18th week
Title
Quality of Life IDQOL-16
Description
Quality of life measured with the IDQOL-16.
Time Frame
At baseline and in the 18th week
Title
Cortisol status
Description
The cortisol status measured with hair analyses.
Time Frame
At baseline and in the 18th week
Title
Microbiome
Description
The micobiome measured with feces analysis.
Time Frame
At baseline and in the 18th week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: intellectual disability living or day care in a health care organization age 12 till 39 years has a at least once a week an aggressive incident. Exclusion Criteria: Pregnancy Breastfeeding people with Williams syndrome, hyperparathyroid or hemochromatosis. Current use of nutritional supplements and refusal to quit this use for the duration of the study. Failure to complete the two-week run-in phase. The use of the following medication: levothyroxine, methyldopa en levodopa
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erik Giltay, MD, PHD
Organizational Affiliation
Leiden University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Trajectum
City
Zwolle
State/Province
Overijssel
ZIP/Postal Code
8017 KZ
Country
Netherlands
Facility Name
Gemiva-SVG
City
Gouda
State/Province
Zuid Holland
ZIP/Postal Code
2803 HG
Country
Netherlands
Facility Name
Schakenbosch
City
Leidschendam
State/Province
Zuid Holland
ZIP/Postal Code
2263 SZ
Country
Netherlands
Facility Name
s Heeren Loo
City
Amersfoort
Country
Netherlands
Facility Name
Amerpoort
City
Baarn
Country
Netherlands
Facility Name
Syndion
City
Gorinchem
Country
Netherlands
Facility Name
Amarant
City
Tilburg
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
10706231
Citation
Schoenthaler SJ, Bier ID. The effect of vitamin-mineral supplementation on juvenile delinquency among American schoolchildren: a randomized, double-blind placebo-controlled trial. J Altern Complement Med. 2000 Feb;6(1):7-17. doi: 10.1089/acm.2000.6.7.
Results Reference
background
PubMed Identifier
12091259
Citation
Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Br J Psychiatry. 2002 Jul;181:22-8. doi: 10.1192/bjp.181.1.22.
Results Reference
background
PubMed Identifier
20014286
Citation
Zaalberg A, Nijman H, Bulten E, Stroosma L, van der Staak C. Effects of nutritional supplements on aggression, rule-breaking, and psychopathology among young adult prisoners. Aggress Behav. 2010 Mar-Apr;36(2):117-26. doi: 10.1002/ab.20335.
Results Reference
background
PubMed Identifier
23625531
Citation
Long SJ, Benton D. A double-blind trial of the effect of docosahexaenoic acid and vitamin and mineral supplementation on aggression, impulsivity, and stress. Hum Psychopharmacol. 2013 May;28(3):238-47. doi: 10.1002/hup.2313. Epub 2013 Apr 29.
Results Reference
background
PubMed Identifier
27166583
Citation
Raine A, Cheney RA, Ho R, Portnoy J, Liu J, Soyfer L, Hibbeln J, Richmond TS. Nutritional supplementation to reduce child aggression: a randomized, stratified, single-blind, factorial trial. J Child Psychol Psychiatry. 2016 Sep;57(9):1038-46. doi: 10.1111/jcpp.12565. Epub 2016 May 11.
Results Reference
background
PubMed Identifier
26573368
Citation
Tammam JD, Steinsaltz D, Bester DW, Semb-Andenaes T, Stein JF. A randomised double-blind placebo-controlled trial investigating the behavioural effects of vitamin, mineral and n-3 fatty acid supplementation in typically developing adolescent schoolchildren. Br J Nutr. 2016 Jan 28;115(2):361-73. doi: 10.1017/S0007114515004390. Epub 2015 Nov 17.
Results Reference
background
PubMed Identifier
27450580
Citation
Gajos JM, Beaver KM. The effect of omega-3 fatty acids on aggression: A meta-analysis. Neurosci Biobehav Rev. 2016 Oct;69:147-58. doi: 10.1016/j.neubiorev.2016.07.017. Epub 2016 Jul 20.
Results Reference
background
PubMed Identifier
35040231
Citation
de Bles NJ, Gast DAA, van der Slot AJC, Didden R, van Hemert AM, Rius-Ottenheim N, Giltay EJ. Lessons learned from two clinical trials on nutritional supplements to reduce aggressive behaviour. J Eval Clin Pract. 2022 Aug;28(4):607-614. doi: 10.1111/jep.13653. Epub 2022 Jan 17.
Results Reference
derived

Learn more about this trial

Reducing Aggression Among People With an Intellectual Disability

We'll reach out to this number within 24 hrs